ID   MESO-12T
AC   CVCL_RP25
DR   Wikidata; Q54905288
RX   PubMed=26891694;
CC   Characteristics: Exhibits the ability to grow to high passage (>30) (PubMed=26891694).
CC   Doubling time: 49.8 hours (Note=In 2% FCS), 37.1 hours (Note=In 10% FCS) (PubMed=26891694).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: No history of asbestos exposure (PubMed=26891694).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
RX   PubMed=26891694; DOI=10.1038/cdd.2015.165; PMCID=PMC4946883;
RA   Chernova T., Sun X.-M., Powley I.R., Galavotti S., Grosso S.,
RA   Murphy F.A., Miles G.J., Cresswell L., Antonov A.V., Bennett J.,
RA   Nakas A., Dinsdale D., Cain K., Bushell M., Willis A.E.,
RA   MacFarlane M.;
RT   "Molecular profiling reveals primary mesothelioma cell lines
RT   recapitulate human disease.";
RL   Cell Death Differ. 23:1152-1164(2016).
//